Literature DB >> 5694692

Response of hyperlipoproteinemia to cholestyramine resin.

H J Fallon, J W Woods.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1968        PMID: 5694692

Source DB:  PubMed          Journal:  JAMA        ISSN: 0098-7484            Impact factor:   56.272


× No keyword cloud information.
  7 in total

1.  The effect of cholestyramine on intestinal absorption.

Authors:  R J West; J K Lloyd
Journal:  Gut       Date:  1975-02       Impact factor: 23.059

2.  Treatment of hyperlipoproteinaemia type II A with a new anion exchange resin secholex.

Authors:  A Gustafson; A Lanner
Journal:  Eur J Clin Pharmacol       Date:  1974       Impact factor: 2.953

Review 3.  Lipid lowering drugs and hyperlipidaemia.

Authors:  R I Levy; B M Rifking
Journal:  Drugs       Date:  1973       Impact factor: 9.546

4.  Use of cholestyramine in treatment of children with familial hypercholesterolaemia.

Authors:  R J West; J K Lloyd
Journal:  Arch Dis Child       Date:  1973-05       Impact factor: 3.791

Review 5.  Cholestyramine.

Authors:  W G Thompson
Journal:  Can Med Assoc J       Date:  1971-02-20       Impact factor: 8.262

6.  The effects of colestipol resin and of colestipol plus clofibrate on the turnover of plasma cholesterol in man.

Authors:  D S Goodman; R P Noble; R B Dell
Journal:  J Clin Invest       Date:  1973-10       Impact factor: 14.808

7.  Ten years clinical experience with partial ileal bypass in management of the hyperlipidemias.

Authors:  H Buchwald; R B Moore; R L Varco
Journal:  Ann Surg       Date:  1974-10       Impact factor: 12.969

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.